Enzon Announces Resignation of Chief Financial Officer
26-Apr-2005
During Mr. Zuerblis' tenure Enzon has transitioned from a small royalty-based pharmaceutical company into one with significant revenues driven by five marketed products. Prior to joining Enzon, Mr. Zuerblis was employed as a senior manager by KPMG LLP, where he served in various advisory roles, including strategic business, tax, audit, and debt and equity financings.
Most read news
Organizations
Enzon Pharmaceuticals
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Dow and Davy License LP OxoSM Technology to YanKuang Cathay Acetyl Chemical Company in China
Go to page
bm becker messtechnik gmbh - Eschborn, Germany
Go to page
Skarke Ventilsysteme - Rimbach-Mitlechtern, Germany
Go to page
Institut für Solarenergieforschung GmbH - Emmerthal, Germany
Go to page
Blaschke GmbH - Meitingen, Germany
Go to page